An experimental drug touted as a breakthrough for treating severe postpartum depression is showing some promising results in a small clinical trial. Sage Therapeutics (SAGE), based in Cambridge, Mass., reported on Tuesday that 7 of the 10 women who took the drug in the trial experienced significant improvement in their depression within 60 hours of …
Abstract Objective: Subanesthetic ketamine doses have been shown to have rapid yet transient antidepressant effects in patients with treatment-resistant depression, which may be prolonged by repeated administration. The purpose of this study was to evaluate the antidepressant effects of a single ketamine infusion, a series of repeated ketamine infusions, and prolongation of response with maintenance …
Everyone experiences occasional feelings of anxiety at some point in their lives. For example, you might feel anxious before taking a test, while making an important decision such as buying a new car or new home, or when you are faced with a particularly challenging project at work. However, for anyone with an anxiety disorder, …
Illustration by Kotryna Zukauskaite Geuris “Jerry” Rivas, a native of New York, was diagnosed with severe obsessive-compulsive disorder when he was 15. Obsessions with organizing and reorganizing the belongings in his bedroom — posters, comic books, videos — took over most of his life. Forced by germ obsessions to compulsively wash and rewash his hands, …
One of the most crippling aspects of anxiety is how isolating it can be. The feelings of fear, worry, and panic, can attack even the most self-assured person and make them feel desperately alone. The irony is that despite these feelings of isolation, anxiety is the most common mental illness in America today. More than …
Anxiety is a typical response when you’re experiencing stressful events throughout your life. For example, if you’re experiencing financial problems, starting a new family, or changing jobs, you may experience some modicum of anxiety. However, if the anxiety symptoms persist or exasperate beyond their trigger and interfere with your everyday life, then you may be …
Key Findings Approximately 6-7% of full-time U.S. workers experienced major depression (MDD) within the past year. The total economic burden of MDD is now estimated to be $210.5 billion per year. For every dollar spent on MDD direct costs in 2010, an additional $1.90 was spent on MDD-related indirect costs. An important study reveals just …
On March 5, 2019 the Food and Drug Administration (FDA) approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made waves for its surprising antidepressant effect. Interestingly, studies from Yale research labs showed that the drug ketamine, which was widely used as …
At last count, about 12% of Americans took antidepressants. Global revenue for antidepressants was about $14.5 billion in 2014 and is projected to grow to nearly $17 billion over the next three years. Clinical depression affects 6.7% of U.S. adults, or about 16 million people, and a growing number of children and teenagers too. It’s …
If you keep up with the news then chances are, you have heard about the exciting recent discoveries that have been made when it comes to ketamine therapy. This is one of those rare instances in which you should actually investigate the hype. Those who suffer from depression know how devastating and isolating it can …
Bespoke Treatment focuses on non-medication treatments that work. We are the first boutique center in Southern California to specialize in personalized TMS therapy, Ketamine treatment, and psychiatry.
